Literature DB >> 30870854

Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China.

Xinting Pan1, Bingbing Chen1, Wenjuan Liu1, Yangfan Li1, Zhijian Hu1, Xu Lin2, Shanghua Xu3, Xian-E Peng4,5.   

Abstract

OBJECTIVES: We aimed to evaluate the associations between body iron stores and the risk of nonalcoholic fatty liver disease (NAFLD) in a Chinese population and explore whether this effect may be modified by other factors.
METHODS: A 1: 1 frequency-matched case-control study was conducted, including 482 NAFLD cases and 490 gender- and age-matched controls. Serum levels of ferritin, hepcidin, and C-reactive protein were measured.
RESULTS: Multivariate logistic regression analysis showed that hepcidin was not associated with NAFLD risk; however, elevated serum ferritin was significantly associated with increased risk of NAFLD (adjusted OR 1.619, 95% CI 1.158-2.267), and hepcidin:ferritin ratio was significantly associated with decreased risk of NAFLD -(OR-adjusted 0.702, 95% CI 0.501-0.984). When stratified by gender, a significant association was found between elevated serum ferritin and hepcidin:ferritin ratio and NAFLD only for women (ORadjusted 2.131, 95% CI 1.151-3.944 and ORadjusted 0.414, 95% CI 0.219-0.781, respectively). A significant multiplicative interaction between central obesity and elevated serum hepcidin was observed (p < 0.05).
CONCLUSIONS: Elevated serum ferritin and hepcidin:ferritin ratio are associated with NAFLD in a Chinese population. Although serum hepcidin is not associated with NAFLD, it may augment the risk effect of central obesity on NAFLD.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Ferritins; Hepcidin; Iron; Nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2019        PMID: 30870854     DOI: 10.1159/000497228

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  5 in total

1.  Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients.

Authors:  Qingling Wang; Mingyu Zhu; Hu Li; Peizhan Chen; Mingjie Wang; Leilei Gu; Xinxin Zhang; Li Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-17       Impact factor: 3.249

2.  Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study.

Authors:  Hewei Peng; Xiaoxu Xie; Xinting Pan; Jing Zheng; Yidan Zeng; Xiaoling Cai; Zhijian Hu; Xian-E Peng
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

3.  Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study.

Authors:  Cristina Galarregui; Bertha Araceli Marin-Alejandre; Nuria Perez-Diaz-Del-Campo; Irene Cantero; J Ignacio Monreal; Mariana Elorz; Alberto Benito-Boillos; José Ignacio Herrero; Josep A Tur; J Alfredo Martínez; M Angeles Zulet; Itziar Abete
Journal:  Diagnostics (Basel)       Date:  2020-11-08

4.  Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study.

Authors:  Jun-Wei Wang; Chun-Hua Jin; Jiang-Feng Ke; Yi-Lin Ma; Yu-Jie Wang; Jun-Xi Lu; Mei-Fang Li; Lian-Xi Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-05       Impact factor: 6.055

5.  Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study.

Authors:  Gregorio Recaredo; Bertha Araceli Marin-Alejandre; Irene Cantero; J Ignacio Monreal; José Ignacio Herrero; Alberto Benito-Boillos; Mariana Elorz; Josep A Tur; J Alfredo Martínez; M Angeles Zulet; Itziar Abete
Journal:  Nutrients       Date:  2019-10-03       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.